The present case report describes the clinical signs and case resolution of an intact 9-year-old male crossbreed dog with spontaneous constipation. The dog presented with abdominal pain, lack of appetite, tenesmus and without signs of defecation in the last 4 days. No important alterations were observed in the complete blood count and biochemistry. A substantial obstruction caused by a faecaloma and a prostate with increased size was observed on X-rays. Benign prostatic hyperplasia (BPH) was confirmed by ultrasonography (size: 48.29 cm3) and by testing the serum canine prostate-specific arginine esterase concentration (105.97 ng/mL). Colon impaction was resolved with rectal enemas within two days. BPH was treated with osaterone acetate. Ultrasonographic checks were performed after 60 and 180 days from the demission and a concrete constant reduction of prostatic volume and of the clinical signs was established. Faecaloma is an uncommon finding in male dogs, and it occurs especially as a consequence of BPH. Colon impaction in patients with BPH is usually subclinical, but it is important to underline how, in severe cases, perforation of the colon and faecal peritonitis can occur, leading to fatal conditions for the animal. In conclusion, prostatic enlargement should always be considered in male dogs suffering from colonic impaction.
Alonge, S., Melandri, M., Leoci, R., Lacalandra, G. M. and Aiudi, G. (2018): Canine prostate specific esterase (CPSE) as an useful biomarker in preventive screening programme of canine prostate: CPSE threshold value assessment and its correlation with ultrasonographic prostatic abnormalities in asymptomatic dogs. Reprod. Domest. Anim. 53, 359–364.
Branam, J. E., Keen, C. L., Ling, G. V. and Franti, C. E. (1984): Selected physical and chemical characteristics of prostatic fluid collected by ejaculation from healthy dogs and from dogs with bacterial prostatitis. Am. J. Vet. Res. 45, 825–829.
Brendler, C. B., Berry, S. J., Ewing, L. L., McCullough, A. R., Cochran, R. C., Strandberg, J. D., Zirkin, B. R., Coffey, D. S., Wheaton, L. G., Hiler, M. L., Bordy, M. J., Niswender, G. D., Scott, W. W. and Walsh, P. C. (1983): Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate. J. Clin. Invest. 71, 1114–1123.
Cohen, S. M., Werrmann, J. G., Rasmusson, G. H., Tanaka, W. K., Malatesta, P. F., Harris, G., Prahalada, S., Jacobs, J. G. and Nett, T. M. (1995): Comparison of the effects of new specific azasteroid inhibitors of steroid 5α-reductase on canine hyperplastic prostate: Suppression of prostatic DHT correlated with prostate regression. The Prostate 26, 55–71.
Cunto, M., Mariani, E., Guido, E. A., Ballotta, G. and Zambelli, D. (2019): Clinical approach to prostatic diseases in the dog. Reprod. Domest. Anim. 54, 815–822.
Eastwood, J. M., McInnes, E. F., White, R. N., Elwood, C. M. and Stock, G. (2005): Caecal impaction and chronic intestinal pseudo-obstruction in a dog. J. Vet. Med. A Physiol. Pathol. Clin. Med. 52, 43–44.
Feeney, D. A., Johnston, G. R., Klausner, J. S., Perman, V., Leininger, J. R. and Tomlinson, M. J. (1987): Canine prostatic disease – Comparison of radiographic appearance with morphologic and microbiologic findings: 30 cases (1981–1985). J. Am. Vet. Med. Assoc. 190, 1018–1026.
Feeney, D. A., Johnston, G. R., Osborne, C. A. and Tomlinson, M. J. (1984): Maximum-distention retrograde urethrocystography in healthy male dogs: Occurrence and radiographic appearance of urethroprostatic reflux. Am. J. Vet. Res. 45, 948–952.
Holst, B. S., Holmroos, E., Friling, L., Hanås, S., Langborg, L. M., Franko, M. A. and Hansson, K. (2017): The association between the serum concentration of canine prostate specific esterase (CPSE) and the size of the canine prostate. Theriogenology 93, 33–39.
Iguer-Ouanda, M. and Verstegen, P. (1997): Effect of finasteride (Proscar MSD) on seminal composition, prostate function and fertility in male dogs. J. Reprod. Fertil. 51, 139–149.
Kamolpatana, K., Johnston, G. R. and Johnston, S. D. (2000): Determination of canine prostatic volume using transabdominal ultrasonography. Vet. Radiol. Ultrasound 41, 73–77.
Kim, J., Yoon, H. and Eom, K. (2018): Imaging diagnosis – Radiography, ultrasonography, and computed tomography of a giant fecaloma causing stercoral perforation of the colon in a dog with a prostatic abscess. Vet. Radiol. Ultrasound 59, E38–E43.
Krawiec, D. R. and Heflin, D. (1992): Study of prostatic disease in dogs: 177 cases (1981–1986). J. Am. Vet. Med. Assoc. 200, 1119–1122.
Kuhnt, N. S. M., Harder, L. K., Nolte, I. and Wefstaedt, P. (2017): Computed tomography: A beneficial diagnostic tool for the evaluation of the canine prostate? BMC Vet. Res. 13, 123.
Laroque, P. A., Prahalada, S., Gordon, L. R., Molon Noblot, S., Bagdon, W. J., Duprat, P., Peter, C. P. and Van Zwieten, M. J. (1994): Effects of chronic oral administration of a selective 5α-reductase inhibitor, finasteride, on the dog prostate. The Prostate 24, 93–100.
Leroy, C., Conchou, F., Layssol-Lamour, C., Deviers, A., Sautet, J., Concordet, D. and Mogicato, G. (2013): Normal canine prostate gland: Repeatability, reproducibility, observer-dependent variability of ultrasonographic measurements of the prostate in healthy intact beagles. J. Vet. Med. C Anat. Histol. Embryol. 42, 355–361.
Mantziaras, G., Alonge, S., Faustini, M. and Luvoni, G. C. (2017): Assessment of the age for a preventive ultrasonographic examination of the prostate in the dog. Theriogenology 100, 114–119.
Nizanski, W., Levy, X., Ochota, M. and Pasikowska, J. (2014): Pharmacological treatment for common prostatic conditions in dogs – benign prostatic hyperplasia and prostatitis: An update. Reprod. Domest. Anim. = Zuchthygiene 49, Suppl. 2, 8–15.
Ruel, Y., Barthez, P. Y., Mailles, A. and Begon, D. (1998): Ultrasonographic evaluation of the prostate in healthy intact dogs. Vet. Radiol. Ultrasound 39, 212–216.
Smith, J. (2008): Canine prostatic disease: A review of anatomy, pathology, diagnosis, and treatment. Theriogenology 70, 375–383.
Trigg, T. E., Wright, P. J., Armour, A. F., Williamson, P. E., Junaidi, A., Martin, G. B., Doyle, A. G. and Walsh, J. (2001): Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. J. Reprod. Fertil. Suppl. 57, 255–261.
Tsutsui, T., Hori, T., Shimizu, M., Orima, H., Kawakami, E. and Fukuda, S. (2000): Regression of prostatic hypertrophy by osaterone acetate in dogs. J. Vet. Med. Sci. 62, 1115–1119.
Tsutsui, T., Hori, T., Shimizu, M., Tatsuzawa, C. and Kawakami, E. (2001): Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy. J. Vet. Med. Sci. 63, 453–456.
Wells, K. L., Bright, R. M. and Wright, K. N. (1995): Caecal impaction in a dog. J. Small Anim. Pract. 36, 455–457.
Westgarth, S., Singh, A. and Vince, A. R. (2013): Subclinical cecal impaction in a dog. Can. Vet. J. 54, 171–173.
Wheaton, L. G., de Klerk, D. P., Strandberg, J. D. and Coffey, D. S. (1979): Relationship of seminal volume to size and disease of the prostate in the Beagle. Am. J. Vet. Res. 40, 1325–1328.
White, R. N. (1997): Chronic caecal faecolithiasis in a dog. J. Small Anim. Pract. 38, 459–461.
Zelli, R., Orlandi, R., Troisi, A., Cardinali, L. and Polisca, A. (2013): Power and pulsed Doppler evaluation of prostatic artery blood flow in normal and benign prostatic hyperplasia-affected dogs. Reprod. Domest. Anim. 48, 768–773.